Singbao International Co Ltd Formerly known as Xingbao International Co Ltd. Singbao International Co. Ltd is a Taiwan-based company principally engaged in the provision of biotechnology medical services. The Company mainly operates through three business segments. The Operation and Management businesses segment is principally engaged in education, training and equipment leasing businesses, as well as the provision of medical cosmetology services and Chinese medicine clinics consultancy services. The Business Development segment is principally engaged in the sales of Chinese medicine and medical cosmetic materials. The Food and Beverage segment is principally engaged in the production and retailing of food. The Company principally operates its businesses in domestic market and overseas markets.
Ford US Equity Research covers more than 4,000 stocks using a proprietary quantitative model that evaluates a company’s earnings strength, its relative valuation and recent price movement. Ford’s five recommendation ratings include strong buy, buy, hold, sell, strong sell. For all stocks in our coverage universe, ratings are generated each week and reflect the fundamental and price data as of the last trading day of the week.
Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind each recommendation and reflect the fundamental and price data as of the last trading day of the week.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.